Join me for @TheALCF Lung Cancer Living Room 1/15 5:30 PM Pacific

Please join lung cancer patients/survivors Teri Kennedy, Jeff Julian, Don Stranathan, Andy Trahan, and me, along with Dr. Amy Moore (Director of Science and Research, Bonnie J. Addario Lung Cancer Foundation, also know as ALCF) Tuesday January 15, 2019 5:30-7:30 pm Pacific Time for a discussion on “Navigating the Latest Advances in Lung Cancer Treatment.” I’ll have an opportunity to talk about The ROS1ders and the research project we created  in partnership with ALCF.

Join us in person in San Carlos, California, watch live on Facebook, or watch later on YouTube or in the Living Room Library.

 

More evidence that reducing sugar doesn’t kill all cancers

5 Things That Happen When You Quit Eating Sugar
Most people are aware that many cancers consume extra glucose (sugar in the blood) in order to grow. That’s why PET scans use radioactive glucose as a tracer to detect cancer.

However, not all cancers can be detected using a PET scan and radioactive glucose. This means not all cancers suck up sugar faster than normal cells. Reducing the available supply of sugar would probably not affect such cancer cells.

 
Now we have more evidence that reducing available sugar does not halt growth of all cancers. Squamous cancer cells in a recent study continued to grow even when deprived of glucose. They simply altered their metabolism to derive energy from the amino acid glutamine. Also, feeding these cancer cells extra glucose did not accelerate their growth.
While we still have much to learn about cancer metabolism, this is yet more evidence that reducing sugar intake won’t cure all cancers.

Study overturns dogma of cancer metabolism theory

New blood test could refine lung cancer screening criteria

Awesome news for Lung Cancer Awareness Month! A relatively simple blood test developed at MD Anderson could help identify those at high risk for developing lung cancer (independent of smoking history). This could lead to refining current lung cancer screening eligibility criteria. #LCAM

Blood Test to Identify Individuals for Lung Cancer Screening (Medscape)

My #WCLC2018 Presentations

I’ll be attending the annual World Conference on Lung Cancer (#WCLC2018) in Toronto Canada later this month.  For those who are interested, I will be making two presentations.  Hope I’ll see you in the audience!

OA10 – Right Patient, Right Target & Right Drug – Novel Treatments and Research Partnerships
Tuesday 9/25 10:00 AM to 12:00 PM
Oral Abstract Session in the Targeted Therapy Track
Moderated by Howard (Jack) West, Jyoti Patel

ES05 – Collaboration Between Stakeholders to Improve Lung Cancer Research 
Tuesday 9/25 15:15 PM to 16:45 PM
Education Session in Advocacy Track
Moderated by Bonnie Addario, Toshiyuki Sawa

Call to Action — Lung Cancer Patients & Doctors in Oregon

 

pills in dollar sign

Are you from Oregon? You may be losing a very important tool to help you survive cancer. Please stand up to keep providing Medicaid coverage of FDA approved comprehensive genomic sequencing. Many lives depend on it!

OREGON CALL TO ACTION!
The state of Oregon Health Authority Health Evidence Review Commission (HERC) recently released proposed guidance to not provide coverage for the use of FDA-Approved Next Generation Sequencing (NGS) tests for cancer patients in the state with Medicaid.

LUNGevity Foundation and Caring Ambassadors are seeking volunteers–both lung cancer survivors and health care professionals–who live in the state of Oregon, to provide testimony at a public meeting on this issue scheduled for 1:00pm-4:00pm on  September 27, 2018 in Wilsonville, Oregon. Ideal testimony would be provided by survivors who have received NGS, or other comprehensive biomarker testing, to guide their treatment and by health care professionals who order, consult, or care for patients who have received NGS, or other comprehensive biomarker testing.For more information or to volunteer, please contact:

  • Anna Pugh, LUNGevity Foundation Director of Public Policy Initiatives, at agpugh@lungevity.org or 240-454-3105 or
  • Cindy Langhorne, Caring Ambassadors Lung Cancer Program Director at cindy@caringambassadors.org or 503-632-9032 ext. 1.

A copy of the comments submitted by LUNGevity Foundation to the HERC can be found here.

Thanks to Matt Ellefson at SURVIVEiT! for helping to make this need known.

A call for more research on “chemobrain”

Image credit: Microsoft

The journal Trends in Neurosciences published an article June 12, 2018 calling for more research into cognitive impairment caused by cancer treatment.    Unfortunately, it’s behind a paywall.  To get an overview of the content,  read Cancer Today’s July 18, 2018 article “What is ‘Chemobrain’?” , which is an interview the article’s lead author, Todd Horowitz of the National Cancer Institute.